New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. - Wikidata - awgldk - TriplyDB

New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.

New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.

http://www.wikidata.org/entity/Q30489770

about

Plectin-1 as a novel biomarker for pancreatic cancer.Tight junctions in human pancreatic duct epithelial cells Dynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformation A compendium of potential biomarkers of pancreatic cancer.Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis.MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice.Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.The secret origins and surprising fates of pancreas tumors A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells.Current status of molecular markers for early detection of sporadic pancreatic cancer.Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers.Analysis of whole genomic expression profiles and screening of the key signaling pathways associated with pancreatic cancer [6]-Gingerol Prevents Disassembly of Cell Junctions and Activities of MMPs in Invasive Human Pancreas Cancer Cells through ERK/NF- κ B/Snail Signal Transduction Pathway Truncation of histone H2A's C-terminal tail, as is typical for Ni(II)-assisted specific peptide bond hydrolysis, has gene expression altering effects Prognostic signature for pancreatic cancer: are we close?Tight junctions in lung cancer and lung metastasis: a review Targeting claudin-4 in human pancreatic cancer.Tight junction-related human diseases.Biomarkers in the diagnosis and early detection of pancreatic cancer.Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer.Role of tight junctions in signal transduction: an update.Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway.Claudin-18 is an early-stage marker of pancreatic carcinogenesis.Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.EUS - Fine- Needle Aspiration Biopsy (FNAB) in the Diagnosis of Pancreatic Adenocarcinoma: A Review.Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2 Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells.Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells.Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma.Tricellulin expression in normal and neoplastic human pancreas.Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer.CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice.Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms.IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth.Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.

P2860

Q24615622-861FA1E3-40DC-4941-A9B8-0F6674FE5A51 Q27012318-3B1414F1-92BB-4081-9EE6-3884966F9CB4 Q28507165-7C0D9BBE-103F-48BE-BA41-8CF2B9271775 Q33428986-725DA5B1-9BA8-4150-AE41-A16D3F018F62 Q33494960-2227B863-97B8-421E-8CCC-C5423D562C46 Q33680759-717EE333-A0A2-4E28-AF6F-E8DF98BB6BD4 Q33818230-EA8EE109-38B3-4B36-B293-E678A27D5BED Q33827679-AD36756D-7692-43C8-BB9F-78CB621ECEF5 Q33992146-95DF6975-0720-43AD-9886-DED23643A29E Q34033442-306EF4B9-CDE1-4E28-BD06-E36839D598DA Q34458903-70511BD4-F251-4225-A5A7-D8FA2B98647C Q34674610-38E6405D-565B-4664-8846-734161FAB9F2 Q34674949-7D8C6402-0FB8-44CB-B653-F76C6C210B39 Q35213733-57667540-9C24-4632-908F-32FFE055D3F6 Q35532292-2227E5C3-343C-4A23-9818-282F56798542 Q36196775-2CEC8269-4832-4288-8B06-38C5DA8C92CD Q37239701-00305169-25A5-404D-95F8-2ADCFD830838 Q37409379-A2616959-A801-44F9-B4F4-1D842505A168 Q37448935-9F014F9A-463E-4448-8030-E3A727EE50A0 Q37991705-E90B9994-2EEC-4565-9B8D-9287AEAC061E Q38026601-C9F5FB73-BF3B-4767-AA1E-0C07F97A5DC4 Q38077200-624DD0B4-93DE-4627-BA55-9496B992E103 Q38089821-9DF56CDB-424C-4756-96D3-31EC2B2C652A Q38242808-2BB4542C-3029-4C80-B385-6847E6FA0BAA Q38594976-F35D44EC-7A36-4750-BFE9-8FE8A633D54E Q38761851-14D693CB-9FD4-42D5-A2E6-F65591847130 Q38819898-3CFA8B3D-18E1-4C8D-BF8F-9CAFBE65FFA0 Q38821198-058389EE-5310-42B7-A55C-C12849AEA337 Q38824403-4E372385-2412-4450-AA4B-59BC1B118B0F Q38839899-824EF31E-B85A-4C73-A0E4-8FA3278C3DBC Q39336324-0A4D6712-7A43-4592-A0B6-583F5F50259F Q39580311-0BF41D7E-D8D6-4CBA-B0B2-5D37492C8625 Q39997881-37849C21-00BC-45E0-B40A-46E9C88FECA0 Q40025036-01E92B2D-D3B8-4849-BE50-3FBFF83C4CF6 Q40679145-96834A44-1081-4161-BA27-07D2145EEC43 Q41117734-2C82D3F7-DADC-47C6-9D0E-F9879414D410 Q42277523-06A16BA3-DA32-4934-93AA-7EAF7349BEDE Q44912928-B63D1FBA-7035-4237-9F46-A267CCB22EF0 Q47136070-BBB54533-A20A-4C1B-97D5-17028FD3C3E9 Q47825611-0228858D-129F-45E9-B194-FB8C240EF888

P2860

New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.

http://www.wikidata.org/entity/Q30489770

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

New markers of pancreatic canc ...... es: claudin 18 and annexin A8.

@ast

New markers of pancreatic canc ...... es: claudin 18 and annexin A8.

@en

type

label

New markers of pancreatic canc ...... es: claudin 18 and annexin A8.

@ast

New markers of pancreatic canc ...... es: claudin 18 and annexin A8.

@en

prefLabel

New markers of pancreatic canc ...... es: claudin 18 and annexin A8.

@ast

New markers of pancreatic canc ...... es: claudin 18 and annexin A8.

@en

P1433

Q30489770-02D30491-9558-409D-BE39-AD5A2FCD15D7

P1476

Q30489770-530A71AD-3351-445C-B6BB-132028659F58

P2093

Q30489770-285868E1-718C-4C7C-9512-9B3FD88BBB1C

Q30489770-4F34C6C5-E50D-4D3A-8771-859852C592C3

Q30489770-517D1585-E9E2-4F1D-9E66-197AE1437647

Q30489770-5AC29E06-8514-4FB0-9E38-20AFF5118E09

Q30489770-5DE36F4C-3C2C-4214-AD0F-F00B01EAD8C2

Q30489770-679EC4E2-0141-46F0-8028-FC150BA9F4BF

Q30489770-85D99D76-68D8-4901-A259-5395A5A8008A

Q30489770-C604E85C-4865-4911-AEDF-4F1D5A07D454

Q30489770-E02BEBAB-0E9D-4C3E-AE2A-7CDB485C4E90

Q30489770-F8654836-5D63-42D5-B959-DD128EEC9698

P2860

Q30489770-05BF7894-E2DE-42DF-A883-4DBCBC721762

Q30489770-12BDD9C7-7D37-45A8-8B97-C08A21FF0608

Q30489770-14E1594A-DE09-4393-BACD-CCCB5AC49144

Q30489770-155EF58F-F9A4-423E-8651-2A954BE53BB5

Q30489770-168BD7B5-04D3-49FE-B705-D2BEAB638F8E

Q30489770-2F73A592-0C2C-4C4F-914A-BF5CA58E37AD

Q30489770-38D80793-DB8D-4CA3-9C5D-2656D3216A29

Q30489770-39655775-6A35-432A-B5D7-9C6F2408DF11

Q30489770-3B314A9C-F60B-4F8C-847E-AB562A1A4BE4

Q30489770-3B9C3555-2C00-4007-880B-48DC0B732B03

P304

Q30489770-7180B65D-EC92-4FF3-A3D2-51C3B0B07A10

P31

Q30489770-48D92AEC-2FC6-4D8A-97E6-DC9CE5E6499E

P356

Q30489770-4E8D3C2C-B984-4E3D-9CE9-78194C8C66CE

P407

Q30489770-424EA176-1E66-4665-B15B-72C007FB5430

P433

Q30489770-8CB24E3D-17DD-496B-ADA7-687E079FB44B

P478

Q30489770-AC981667-EC67-42A9-9213-A7E8B1C29BD1

P50

Q30489770-029AFD30-D08E-413A-BC2D-B9CCB663B5F4

Q30489770-109259F5-443E-4386-8E44-CF532CF43E07

P577

Q30489770-291E5EAE-CB61-495F-9727-B65B4B4BF3C8

P698

Q30489770-A71F2986-9789-4921-BE7B-63E7844C34B1

P932

Q30489770-BFB000AD-0D48-4304-A54C-850EC556E3B9

P356

PAS.0B013E31815701F3

P1433

The American Journal of Surgical Pathology

P1476

New markers of pancreatic canc ...... es: claudin 18 and annexin A8.

@en

P2093

Akhilesh Pandey

http://www.w3.org/2001/XMLSchema#string

Anirban Maitra

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Infante

http://www.w3.org/2001/XMLSchema#string

Jordan Winter

http://www.w3.org/2001/XMLSchema#string

Kathleen Murphy

http://www.w3.org/2001/XMLSchema#string

Peter B Illei

http://www.w3.org/2001/XMLSchema#string

Raheela Ashfaq

http://www.w3.org/2001/XMLSchema#string

Rajni Sharma

http://www.w3.org/2001/XMLSchema#string

Richard Schulick

http://www.w3.org/2001/XMLSchema#string

Zarir E Karanjawala

http://www.w3.org/2001/XMLSchema#string

P2860

The claudin gene family: expression in normal and neoplastic tissues

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast

Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray

Mesothelin: a new target for immunotherapy

Annexins: linking Ca2+ signalling to membrane dynamics

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

Gene expression profiles of pancreatic cancer and stromal desmoplasia.

P304

188-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAS.0B013E31815701F3

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Michael Goggins

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18223320

http://www.w3.org/2001/XMLSchema#string

P932

2678811

http://www.w3.org/2001/XMLSchema#string